BIOINVENT FINANS AB
Clinical-stage biotech developing novel immuno-oncology antibody therapies for cancer.
Yleiskatsaus
- Tuntematon
- Työntekijät
- Tuntematon
- Liikevaihto
- 2001
- Perustettu
Avainpäättäjät
Cecilia Hofvander
VP Investor Relations
Thomas Hecht
Member of the Board
Anette Mårtensson
Employee deputy, Member of the Board
Nanna Lüneborg
Member of the Board
+18 lisää yhteystietoja Funnelfeedrissä
Kuvaus
BioInvent International AB is a clinical-stage company focused on discovering and developing novel antibody therapeutics for cancer treatment. The core of their work lies in immuno-oncology, leveraging deep expertise in immunology, cancer biology, and antibody biology. They utilize their proprietary...